Treatment of chronic hepatitis C virus infection

Citation
Sdh. Malnick et al., Treatment of chronic hepatitis C virus infection, ANN PHARMAC, 34(10), 2000, pp. 1156-1164
Citations number
80
Categorie Soggetti
Pharmacology
Journal title
ANNALS OF PHARMACOTHERAPY
ISSN journal
10600280 → ACNP
Volume
34
Issue
10
Year of publication
2000
Pages
1156 - 1164
Database
ISI
SICI code
1060-0280(200010)34:10<1156:TOCHCV>2.0.ZU;2-F
Abstract
OBJECTIVE: To review the literature on the treatment of chronic hepatitis C virus (HCV) infection. DATA SOURCES: MEDLINE search (1986-December 1999) using key words such as H CV, hepatitis, non-A and non-B hepatitis, as well as terms regarding treatm ent during that time period. DATA SYNTHESIS: HCV infection was initially treated with interferon monothe rapy, but only a minority of patients responded to long-term therapy. A hig her rate of response in both interferon-naive patients and interferon-relap sers has been achieved by using the combination of interferon and ribavarin . Other treatment regimens including high-dose interferon protocols, ursode oxycholic acid, amantadine, and nonsteroidal antiinflammatory drugs have be en less promising. Many alternative therapies are being investigated. CONCLUSIONS: HCV infection is a major public health problem. It is now poss ible to achieve a cure in nearly 50% of the patients with this infection. M any additional therapies are being evaluated in order to achieve a higher c ure rate.